Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Images Drug Delivery Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11082
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide range of services such as clinical rescue, microdosing, generics development, controlled release, gamma scintigraphy and clinical and PK studies among others. The company’s OralogiK technology is a drug delivery system providing timed release, sustained release and the opportunity for complex bi- and tri-phasic release of one or multiple drugs. It provides clinical services such as study documentation design, protocol development and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study reports. BDD is headquartered in Glasgow, Scotland, the UK.

Bio-Images Drug Delivery Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Bio-Images Drug Delivery Raises USD2.8 Million in Venture Financing 10
Licensing Agreements 11
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 11
Novartis Pharma Enters into Licensing Agreement with Bio-Images Drug Delivery 12
Bio-Images Drug Delivery Ltd – Key Competitors 13
Bio-Images Drug Delivery Ltd – Key Employees 14
Bio-Images Drug Delivery Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 12, 2018: BDD Appoints Ex-AstraZeneca VP Joanne Kelley as Non-executive Director to the Board 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Images Drug Delivery Raises USD2.8 Million in Venture Financing 10
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 11
Novartis Pharma Enters into Licensing Agreement with Bio-Images Drug Delivery 12
Bio-Images Drug Delivery Ltd, Key Competitors 13
Bio-Images Drug Delivery Ltd, Key Employees 14

List of Figures
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edenor SA (EDN3):企業の財務・戦略的SWOT分析
    Edenor SA (EDN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Biomerica Inc (BMRA):企業の製品パイプライン分析
    Summary Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose v …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • Coca-Cola Amatil Limited:戦略・SWOT・企業財務分析
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務分析
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • SynergEyes Inc-医療機器分野:企業M&A・提携分析
    Summary SynergEyes Inc (SynergEyes) is a medical device company that offers contact lenses. The company offers hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It provides ultrahealth hybrid len …
  • Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析
    Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ormat Technologies Inc (ORA):電力:M&Aディール及び事業提携情報
    Summary Ormat Technologies, Inc. (Ormat), is a vertically integrated company that focuses on the geothermal and recovered energy generation. The company designs, develops, builds, owns, and operates the geothermal and recovered energy generation (REG) power plants. Ormat also supplies geothermal and …
  • CP Kelco:企業の戦略・SWOT・財務情報
    CP Kelco - Strategy, SWOT and Corporate Finance Report Summary CP Kelco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • JinkoSolar Holding Co Ltd (JKS)-エネルギー分野:企業M&A・提携分析
    Summary JinkoSolar Holding Co., Ltd. (JinkoSolar) is a manufacturer of solar products. The company manufactures and markets solar power products such as silicon ingots, silicon wafers, solar PV cells, and monocrystalline and multicrystalline photovoltaic (PV) panels. JinkoSolar distributes the solar …
  • Copa Holdings, S.A. (CPA):企業の財務・戦略的SWOT分析
    Copa Holdings, S.A. (CPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EV Energy Partners LP:企業のM&A・事業提携・投資動向
    EV Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EV Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • PBF Energy Inc (PBF):石油・ガス:M&Aディール及び事業提携情報
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Cleveland-Cliffs Inc:企業の戦略・SWOT・財務分析
    Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report Summary Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Life Insurance Corporation of India:企業の戦略的SWOT分析
    Life Insurance Corporation of India - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Premaitha Health Plc (NIPT):医療機器:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Koss Corp (KOSS):企業の財務・戦略的SWOT分析
    Summary Koss Corp (Koss) operates as an electronic equipment company that designs, manufactures and markets stereo headphones and other related accessory products. The company provides products such as full size headphones, earbuds and in-ear headphones, ear clip headphones, on-ear headphones, in-li …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆